AAREY DRUGS & PHARM LTD Share Price

AAREY DRUGS & PHARM LTD Share Price

NSE: AAREYDRUGS
|
Pharmaceuticals
|
S Cap
₹ 95.71
-₹4.27 (-4.27%)
1D
Last updated 10 Sep, 2026, 15:56 IST

AAREY DRUGS & PHARM LTD Share Price Today

As of 11 Sep 2026, AAREY DRUGS & PHARM LTD share price is ₹95.71. The stock opened at ₹101.29, compared to its previous close of ₹99.98. During today's trading session, AAREY DRUGS & PHARM LTD share price moved in the range of ₹94.99 to ₹101.29, with an average price of ₹98.14 for the day. Looking at its last 52-week, the stock has touched a low of ₹50.31 and a high of ₹101.29. On the performance front, AAREY DRUGS & PHARM LTD share price has increased by 38.23% over the last six months and is up 31.67% on a year-on-year basis.

₹94.99
4.27% down today
₹101.29
1D LOW
1D HIGH

AAREY DRUGS & PHARM LTD Returns Calculator

Circuit
L
H
₹90.93
₹100.49
52-week
L
H
₹50.31
₹101.29

About AAREY DRUGS & PHARM LTD

AAREY DRUGS & PHARM LTD Share Price
ISIN
INE198H01019
Sector Market Cap
₹ 307.88 Cr

Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxofylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Industrial Intermediates, Chlorinated Solvents, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.

AAREY DRUGS & PHARM LTD Financial Highlights

  • Revenue: AAREY DRUGS & PHARM LTD reported revenue of ₹478.37 crore in FY26 vs ₹483.75 crore in FY25. It showed a decrease of 1.11% on a yearly basis.
  • Operating Profit: AAREY DRUGS & PHARM LTD reported an operating profit of ₹5.41 crore in FY26 vs ₹6.10 crore in FY25. It showed a decrease of 11.31% on a year-on-year basis.
  • Net Profit: AAREY DRUGS & PHARM LTD reported a net profit of ₹3.97 crore in FY26 vs ₹4.02 crore in FY25. It showed a decrease of 1.24% on a yearly basis.

AAREY DRUGS & PHARM LTD Quarterly Result Highlights

  • AAREY DRUGS & PHARM LTD reported revenue of ₹46.35 crore in Jun 2026, compared with ₹189.04 crore in Mar 2026, representing a decrease of 75.48% on a quarter-on-quarter (QoQ) basis.
  • AAREY DRUGS & PHARM LTD reported an operating profit of ₹0.52 crore in Jun 2026, compared with ₹1.28 crore in Mar 2026, representing a decrease of 59.38% on a quarter-on-quarter (QoQ) basis.
  • AAREY DRUGS & PHARM LTD reported a profit of ₹1.02 crore in Jun 2026, compared with ₹1.56 crore in Mar 2026, reflecting a decrease of 34.62% on a QoQ basis.
  • The earnings per share (EPS) of AAREY DRUGS & PHARM LTD stood at ₹1.42 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
42.79%
FII
4.41%
Other DII
1.49%
Retail and other
51.30%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20253.86%
Mar 20264.18%
Jun 20264.80%
Aug 20264.41%
Mkt Cap Cr
294.66
P/E
70.70
P/B
1.77
ROE
2.64%
D/E
0.33
ROCE
5.20%
Div. Yield
0.00%
EPS(TTM)
1.39
Turnover
1.40
EV/EBITDA
27.35
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.40%
Quick Ratio
0.00
Curr. Ratio
2.74
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Aarey Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Aarey Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,316.0036.915.3513.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,51,737.0085.3614.9015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,87,460.0086.9522.2925.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,12,618.0024.284.1118.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,515.0033.223.2411.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,04,456.0095.9419.7416.77%0.4016.14%97.200.10%0.6713.72
Aurobindo Pharma97,238.9025.882.539.25%0.1911.76%394.820.24%0.3841.58
Lupin95,660.0017.094.2323.76%0.0424.88%659.000.87%0.57129.18
Dr. Reddy's Laboratories95,420.6029.912.5011.07%0.1812.54%377.950.70%0.4138.68
Mankind Pharma93,596.0044.875.6911.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

AAREY DRUGS & PHARM LTD Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹473.94₹395.62₹418.96₹492.76
Other Income₹9.81₹6.96₹2.73₹2.67
Total Revenue₹483.76₹402.58₹421.69₹495.43
Total Expenses₹477.65₹397.24₹415.68₹485.39
Profit Before Tax₹6.10₹5.34₹6.01₹10.04
Tax₹2.08₹0.66₹2.24₹3.48
Profit After Tax₹4.02₹4.68₹3.77₹6.55
EPS - Basic₹1.42₹1.84₹1.49₹2.72
EPS - Diluted₹10.00₹10.00₹1.49₹2.72

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹6.10₹5.34₹6.01₹10.03
Income before WC changes₹12.71₹10.75₹10.45₹14.02
Change in Assets₹16.84-₹11.09-₹50.86-₹7.39
Change in Liabilities-₹17.34-₹1.33₹41.40-₹2.54
Change in WC-₹0.50-₹12.42-₹9.45-₹9.93
Cash flow from Operations₹10.30-₹2.99-₹1.28₹0.50
Cash flow from Investing-₹5.94-₹1.70₹0.44-₹3.21
Cash flow from Financing-₹4.48₹5.58₹1.35₹2.25
Total Cash Flow-₹0.12₹0.89₹0.51-₹0.46
Cash (Start of the year)₹1.59₹0.71₹0.19₹0.65
Cash (End of the year)₹1.47₹1.59₹0.71₹0.19

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹24.98₹20.71₹20.72₹26.35
Current Assets₹265.61₹282.59₹270.61₹218.82
Total Assets₹290.59₹303.29₹291.32₹245.17
Current Liabilities₹149.21₹166.55₹168.14₹126.74
Net Current Asset₹116.40₹116.04₹102.47₹92.08
Non-Current Liabilities₹2.91₹3.97₹5.78₹4.80
Equity Capital₹138.48₹132.77₹117.41₹113.64
Total Equity & Liabilities₹290.59₹303.29₹291.32₹245.17
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
95.71
590
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 590
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
63.11
Neutral
ATR (14)
4.32
Neutral
STOCH(9,6)
62.5
Neutral
STOCH RSI (14)
68.58
Neutral
ADX(9)
42.8
Bearish
UO(9)
59.69
Neutral
ROC(12)
24.44
Bullish
WillR(14)
-20.91
Neutral
Period
Simple value
Exponential vaue
5D
97.36
96.53
10D
94.27
93.96
20D
87.96
90.13
50D
83.6
85.76
100D
84.47
82.53
Volume trend — traded volume by day
10 Sep0L
9 Sep2L
8 Sep1L
7 Sep2L
4 Sep1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
AAREY DRUGS & PHARM LTD Share Price
AAREY DRUGS & PHARM LTD
Pharmaceuticals
Add Stock
Add Another

AAREY DRUGS & PHARM LTD Share Price FAQs

AAREY DRUGS & PHARM LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837